American Journal of Obstetrics & Gynecology
Volume 193, Issue 3, Supplement , Pages 1105-1109, September 2005

Targeting the respiratory muscles of fetal sheep for prenatal gene therapy for Duchenne muscular dystrophy

  • Boaz Weisz, MD

      Affiliations

    • Department of Obstetrics and Gynaecology, University College London
    • Corresponding Author InformationReprint requests: Dr Boaz Weisz, Department of Obstetrics and Gynaecology, University College London, 86-96 Chenies Mews, WC1E6HX, London, UK.
  • ,
  • Anna L. David, MD

      Affiliations

    • Department of Obstetrics and Gynaecology, University College London
  • ,
  • Lisa G. Gregory, PhD

      Affiliations

    • Imperial College of Science, Technology and Medicine, University of London, Section of Molecular Genetics, Gene Therapy Research Group
  • ,
  • Dany Perocheau, BSc

      Affiliations

    • Department of Obstetrics and Gynaecology, University College London
  • ,
  • Ali Ruthe, BSc

      Affiliations

    • Department of Obstetrics and Gynaecology, University College London
  • ,
  • Simon N. Waddington, PhD

      Affiliations

    • Imperial College of Science, Technology and Medicine, University of London, Section of Molecular Genetics, Gene Therapy Research Group
  • ,
  • Mike Themis, PhD

      Affiliations

    • Imperial College of Science, Technology and Medicine, University of London, Section of Molecular Genetics, Gene Therapy Research Group
  • ,
  • Terry Cook, MD

      Affiliations

    • Department of Histopathology, Imperial College of Science, Technology and Medicine, University of London, London, United Kingdom
  • ,
  • Charles Coutelle, PhD

      Affiliations

    • Imperial College of Science, Technology and Medicine, University of London, Section of Molecular Genetics, Gene Therapy Research Group
  • ,
  • Charles H. Rodeck, MD

      Affiliations

    • Department of Obstetrics and Gynaecology, University College London
  • ,
  • Donald M. Peebles, MD

      Affiliations

    • Department of Obstetrics and Gynaecology, University College London

Received 24 February 2005; received in revised form 29 April 2005; accepted 26 May 2005.

Objective

Duchenne muscular dystrophy (DMD) is a lethal degenerative muscular disease. Fetal gene therapy may correct the primary genetic defect. Our aim was to achieve expression of a reporter gene in the respiratory muscles of early gestation fetal sheep.

Study design

An adenovirus vector containing the β-galactosidase reporter gene (AdRSVβgal) was injected into the thoracic musculature (n=3) and pleural cavity (n=6) of fetal sheep (61-67 days' gestation) under ultrasound guidance. Tissues were harvested after 48 hours and site and intensity of β-galactosidase expression were assessed.

Results

Limited transgene expression observed after a single injection was improved by multiple injections, but remained localized. Ultrasound-guided creation of a hydrothorax led to an increase in the intensity of β-galactosidase expression (ELISA). X-gal staining and immunohistochemistry showed that vector spread was confined to the innermost intercostal musculature.

Conclusion

Ultrasound-guided injection can deliver gene therapy vectors to the fetal pleural cavity and achieve transduction of the respiratory muscles.

Key words: Gene therapy, Fetal gene therapy, Duchenne muscular dystrophy, Ultrasound, Fetal medicine

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Presented at the Twenty-Fifth Annual Meeting of the Society for Maternal Fetal Medicine, February 7-12, 2005, Reno, Nev.

PII: S0002-9378(05)00980-4

doi:10.1016/j.ajog.2005.06.077

American Journal of Obstetrics & Gynecology
Volume 193, Issue 3, Supplement , Pages 1105-1109, September 2005